Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Issue 99, 2022

Article

Nguyễn Thị Lệ Thuý: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Phạm Quốc Khánh: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Bộ môn Nội, Đại học Y Dược, Đại học Quốc gia Hà Nội; Phạm Trần Linh: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Bộ môn Nội, Đại học Y Dược, Đại học Quốc gia Hà Nội; Viên Hoàng Long: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Bộ môn Nội, Đại học Y Dược, Đại học Quốc gia Hà Nội; Nguyễn Duy Tuấn: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Trần Tuấn Việt: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Bộ môn Tim mạch, Đại Học Y Hà Nội; Nguyễn Thị Hải Yến: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai;
Published: November 1, 2021
Views: 153

Abstract

Hypertension (HTN) is one of the most common cardiovascular diseases and causes cardiovascular death globally. Target organ damage needs to be evaluated in which cardiac function is an important point. The electrocardiogram and echocardiogram are routine tests, those are easy to perform and provide many important parameters for evaluating left ventricular systolic and diastolic function. In the world, many authors are interested in diastolic dysfunction in patients with essential hypertension. In Vietnam, there are relatively few studies on this group of patients, this study aims to evaluate clinical and subclinical characteristics in hypertensive patients with diastolic dysfunction.
Objectives: To evaluate clinical characteristics, echocardiographic parameters and 12-lead standard electrocardiogram in hypertensive patients with diastolic dysfunction.
Methods: A cross-sectional descriptive study on 169 patients with essential hypertension, including 85 patients with diastolic dysfunction and 84 patients without diastolic dysfunction. The patients were examined, taken medical history and indicated for electrocardiogram, transthoracic echocardiogram, basic blood test.
Results: The mean age was 63.3 ± 10.6 years. The group with stage 2 of left ventricular diastolic dysfunction had a higher mean age than the group without diastolic dysfunction (71.8 ± 8.8 yearrs versus 59.3 ± 10.4 years). The proportion of females is 59.8% and of male is 40.2%. The prevalence of overweight in the group with left ventricular diastolic dysfunction was higher than in the group without diastolic dysfunction (53.1% versus 46.9%). All patients in study had concentric left ventricular wall thickening
with RWT > 0.42, the group with stage 2 of left ventricular diastolic dysfunction had a higher rate of left ventricular hypertrophy than the group without diastolic dysfunction (54.1% and 25% with p < 0.001). The left ventricular diastolic dysfunction group had a larger left atrial volume (41.7 ± 4.4 ml/m2 in stage 2 group and 37.7 ± 3.7 ml/m2 in stage 1 group compared with 26.9 ± 6.1 ml/m2 in group without diastolic dysfunction, p<0.001). The mean heart rate of the group with diastolic dysfunction was higher (79.2 ± 8.0 bpm in stage 2 group and 77.5 ± 10.2 bpm in stage 1 group versus 70.2 ± 6.4 bpm in group without diastolic dysfunction, p < 0.01). P wave, PQ, QT, and QTc intervals were all longer in the group with diastolic dysfunction than in the group without diastolic dysfunction, although the heart rate of this group was higher, the difference was statistically significant with p <0.01. The rate of left ventricular hypertrophy based on the Sokolow-Lyon index was higher in the group with left ventricular diastolic dysfunction (29.4%) than in the group without diastolic dysfunction (13.1%), p < 0.001.

Conclusion: Hypertension patients with diastolic dysfunction had a higher mean age, BMI, and proportion of overweight. The rate of left ventricular hypertrophy on echocardiography was higher in the group with diastolic dysfunction. The mean heart rate of the group with left ventricular diastolic dysfunction was higher, the P wave duration, PQ, QT and QTc intervals were longer, the Sokolow-Lyon index of the diastolic dysfunction group was higher than the group without diastolic dysfunction.

References

1.
1. Caforio ALP, Pankuweit S, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34(33):2636-48.
2.
2. Cooper Jr. LT, Keren A, Sliwa K. The Global Burden of Myocarditis: Part 1: A Systematic Literature Review for the Global Burden of Diseases, Injuries, and Risk Factors. GlobalHeart. 2014;9(1):121.
3.
3. Huỳnh Phúc Nguyên, Lê Kim Thạch. Đặc điểm lâm sàng của các trường hợp viêm cơ tim tại khoa nội tim mạch bệnh viện Chợ Rẫy. TạpchítimmạchhọcViệtNam. 2014; 68:112-117.
4.
4. Shauer A, Gotsman I, Keren A, et al. Acute Viral Myocarditis: Current Concepts in Diagnosis and Treatment. 2013;15:6.
5.
5. Schultheiss H-P, Kuhl U, Cooper LT. The management of myocarditis. European Heart Journal. 2011;32(21):2616-2625.
6.
6. Sagar S, Liu PP, Cooper LT. Myocarditis. TheLancet. 2012;379(9817):738-747.
7.
7. Schultz JC, Hilliard AA, Cooper LT, Rihal CS. Diagnosis and Treatment of Viral Myocarditis. Mayo Clinic Proceedings. 2009;84(11):1001-1009.
8.
8. Xu D, Zhao R-C, Gao W-H. A Risk Prediction Model for In-hospital Mortality in Patients with Suspected Myocarditis. Chinese Medical Journal. 2017;130(7):782-790.
9.
9. Lauer B, Niederau C, et al. Cardiac Troponin T in Patients With Clinically Suspected Myocarditis. Journalof the American College of Cardiology. 1997;30(5):1354-1359.
10.
10. Rodriguez-Gonzalez M, Sanchez-Codez MI, Lubian-Gutierrez M, Castellano-Martinez A. Clinical presentation and early predictors for poor outcomes in pediatric myocarditis: A retrospective study. World Journal of Clinical Cases. 2019;7(5):548-561.

Files

Article Views153
Document Views2
Downloads0
Section NGHIÊN CỨU LÂM SÀNG